Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Administration timing of oral iron and hemoglobin response in iron deficiency anemia
IRCT20210503051166N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Iron in iron deficiency anemia (IDA) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Increase in hemoglobin level and Iron profile. Started Apr 2023; status: completed.
02
Drugs
Iron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on IRCT20210503051166N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210503051166N2.